View in EDS

Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity.

Saved in:
Bibliographic Details
Title: Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity.
Authors: Curtis NJ; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK., Mooney L; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK., Hopcroft L; iMED Oncology, AstraZeneca, Cambridge, UK., Michopoulos F; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK., Whalley N; iMED Oncology, AstraZeneca, Cambridge, UK., Zhong H; MedImmune, One MedImmune Way, Gaithersburg, MD, USA., Murray C; iMED DSM, AstraZeneca, Cambridge, UK.; C4X Discovery, Manchester, UK., Logie A; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK., Revill M; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK., Byth KF; iMED Oncology, AstraZeneca, Gatehouse Park, Waltham, Massachusetts, MA, USA., Benjamin AD; iMED DSM, AstraZeneca, Cambridge, UK., Firth MA; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK., Green S; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK., Smith PD; iMED Oncology, AstraZeneca, Cambridge, UK., Critchlow SE; iMED Oncology, AstraZeneca, Cambridge, UK.
Source: Oncotarget [Oncotarget] 2017 May 25; Vol. 8 (41), pp. 69219-69236. Date of Electronic Publication: 2017 May 25 (Print Publication: 2017).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29050199
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Curtis+NJ%22">Curtis NJ</searchLink>; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK.<br /><searchLink fieldCode="AU" term="%22Mooney+L%22">Mooney L</searchLink>; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK.<br /><searchLink fieldCode="AU" term="%22Hopcroft+L%22">Hopcroft L</searchLink>; iMED Oncology, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Michopoulos+F%22">Michopoulos F</searchLink>; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK.<br /><searchLink fieldCode="AU" term="%22Whalley+N%22">Whalley N</searchLink>; iMED Oncology, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Zhong+H%22">Zhong H</searchLink>; MedImmune, One MedImmune Way, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Murray+C%22">Murray C</searchLink>; iMED DSM, AstraZeneca, Cambridge, UK.; C4X Discovery, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Logie+A%22">Logie A</searchLink>; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK.<br /><searchLink fieldCode="AU" term="%22Revill+M%22">Revill M</searchLink>; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK.<br /><searchLink fieldCode="AU" term="%22Byth+KF%22">Byth KF</searchLink>; iMED Oncology, AstraZeneca, Gatehouse Park, Waltham, Massachusetts, MA, USA.<br /><searchLink fieldCode="AU" term="%22Benjamin+AD%22">Benjamin AD</searchLink>; iMED DSM, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Firth+MA%22">Firth MA</searchLink>; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK.<br /><searchLink fieldCode="AU" term="%22Green+S%22">Green S</searchLink>; iMED Oncology, AstraZeneca, Alderley Park, Cheshire, UK.<br /><searchLink fieldCode="AU" term="%22Smith+PD%22">Smith PD</searchLink>; iMED Oncology, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Critchlow+SE%22">Critchlow SE</searchLink>; iMED Oncology, AstraZeneca, Cambridge, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101532965%22">Oncotarget</searchLink> [Oncotarget] 2017 May 25; Vol. 8 (41), pp. 69219-69236. <i>Date of Electronic Publication: </i>2017 May 25 (<i>Print Publication: </i>2017).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals%22">Impact Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532965 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-2553 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219492553%22">19492553 </searchLink><i>NLM ISO Abbreviation: </i>Oncotarget <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29050199
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.18632/oncotarget.18215
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 69219
    Titles:
      – TitleFull: Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Curtis NJ
      – PersonEntity:
          Name:
            NameFull: Mooney L
      – PersonEntity:
          Name:
            NameFull: Hopcroft L
      – PersonEntity:
          Name:
            NameFull: Michopoulos F
      – PersonEntity:
          Name:
            NameFull: Whalley N
      – PersonEntity:
          Name:
            NameFull: Zhong H
      – PersonEntity:
          Name:
            NameFull: Murray C
      – PersonEntity:
          Name:
            NameFull: Logie A
      – PersonEntity:
          Name:
            NameFull: Revill M
      – PersonEntity:
          Name:
            NameFull: Byth KF
      – PersonEntity:
          Name:
            NameFull: Benjamin AD
      – PersonEntity:
          Name:
            NameFull: Firth MA
      – PersonEntity:
          Name:
            NameFull: Green S
      – PersonEntity:
          Name:
            NameFull: Smith PD
      – PersonEntity:
          Name:
            NameFull: Critchlow SE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 05
              Text: 2017 May 25
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1949-2553
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 41
          Titles:
            – TitleFull: Oncotarget
              Type: main
ResultId 1